In2Clinical SRL
In2Clinical reported total assets of 18,773 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of In2Clinical shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -21 % Total assets -31 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
In2Clinical's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
In2Clinical's financial analysis
- Solvency92.3%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of In2Clinical
In2Clinical's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0781.726.958
- VAT number
- BE0781726958
- Peppol
- Registered · 0208:0781726958 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Feb 2022
- Registered office
- 3190 Boortmeerbeek
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
In2Clinical (SRL) has been based in Boortmeerbeek since 2022, active in: business and other management consultancy activities. For 2025, it reports a net loss of 5,472 € and equity of 17,331 €; its revenue is not published. Its solvency stands at 92.3%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to In2Clinical
Companies in the same business, of comparable size and area, outside its group.
- Maior Business and other management consultancy activities Merelbeke-Melle · balance sheet 18,707 €
- Altesa Business and other management consultancy activities Liège · balance sheet 18,944 €
- Fuesion Business and other management consultancy activities Antwerp · balance sheet 18,308 €
- Strik Consulting Business and other management consultancy activities Bonheiden · balance sheet 15,176 €
- CPM Agency Business and other management consultancy activities Molenbeek-Saint-Jean · balance sheet 17,993 €
- Bleurmont Conseil & Developpement Business and other management consultancy activities Chaudfontaine · balance sheet 19,671 €
- Veron Business and other management consultancy activities Herk-de-Stad · balance sheet 19,701 €
- Garde la Pêche Business and other management consultancy activities Molenbeek-Saint-Jean · balance sheet 19,751 €
Frequently asked questions about In2Clinical
What is the revenue of In2Clinical?
In2Clinical files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of In2Clinical?
In Belgium, the VAT number is the company number prefixed with BE: BE0781726958 for In2Clinical, if the company is VAT-registered. Its company number (CBE) is 0781.726.958.
Where is the registered office of In2Clinical?
According to the CBE register, the registered office of In2Clinical is in 3190 Boortmeerbeek.
What is the equity of In2Clinical?
At the close of the 2025 financial year, the equity of In2Clinical amounts to 17,331 €, a solvency of 92.3% of total assets.
Who manages In2Clinical?
The register lists 4 active mandates at In2Clinical. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of In2Clinical
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →